$KYMR
Kymera Therapeutics, Inc.

2021 Q4 Form 10-Q Financial Statement

#000095017021003911 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $15.28M $20.34M $14.53M
YoY Change 19.43% 39.93% 1429.79%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $11.74M $10.67M $6.840M
YoY Change 126.64% 55.95% 356.0%
% of Gross Profit
Research & Development $37.53M $38.31M $15.78M
YoY Change 84.06% 142.78% 39.5%
% of Gross Profit
Depreciation & Amortization $689.0K $700.0K $500.0K
YoY Change 37.8% 40.0% 150.0%
% of Gross Profit
Operating Expenses $49.27M $48.97M $22.62M
YoY Change 92.68% 116.54% 76.54%
Operating Profit -$28.64M -$8.083M
YoY Change 254.29%
Interest Expense $94.00K $55.00K $100.0K
YoY Change -6.0% -45.0% -77.27%
% of Operating Profit
Other Income/Expense, Net $55.00K $97.00K
YoY Change -43.3% -78.0%
Pretax Income -$33.90M -$28.58M -$7.990M
YoY Change 167.14% 257.72% -30.04%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$33.90M -$28.58M -$7.986M
YoY Change 167.14% 257.9% -30.07%
Net Earnings / Revenue -221.93% -140.55% -54.95%
Basic Earnings Per Share -$0.56
Diluted Earnings Per Share -$659.1K -$563.6K -$179.8K
COMMON SHARES
Basic Shares Outstanding 51.39M 50.71M
Diluted Shares Outstanding 50.71M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $442.4M $536.4M $293.8M
YoY Change 49.36% 82.54%
Cash & Equivalents $47.98M $156.8M $54.59M
Short-Term Investments $394.4M $379.6M $239.2M
Other Short-Term Assets $8.720M $5.772M $2.900M
YoY Change 85.53% 99.03%
Inventory
Prepaid Expenses
Receivables $135.0K $1.573M $600.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $451.3M $543.7M $297.4M
YoY Change 49.26% 82.85%
LONG-TERM ASSETS
Property, Plant & Equipment $11.88M $12.18M $10.98M
YoY Change 9.59% 10.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $125.2M $74.69M $187.5M
YoY Change -22.96% -60.16%
Other Assets $2.022M $716.0K $1.590M
YoY Change 6640.0% -54.97%
Total Long-Term Assets $154.6M $98.72M $210.0M
YoY Change -16.34% -52.99%
TOTAL ASSETS
Total Short-Term Assets $451.3M $543.7M $297.4M
Total Long-Term Assets $154.6M $98.72M $210.0M
Total Assets $605.9M $642.5M $507.4M
YoY Change 24.37% 26.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.005M $5.033M $3.979M
YoY Change -8.31% 26.49%
Accrued Expenses $22.97M $19.22M $7.874M
YoY Change 122.37% 144.08%
Deferred Revenue $61.74M $66.23M $92.01M
YoY Change -33.29% -28.02%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.138M $1.189M $700.0K
YoY Change 62.57% 69.86%
Total Short-Term Liabilities $92.54M $94.49M $107.3M
YoY Change -16.34% -11.92%
LONG-TERM LIABILITIES
Long-Term Debt $1.140M $1.347M $800.0K
YoY Change 90.0% 68.38%
Other Long-Term Liabilities $66.00K $76.00K $104.6M
YoY Change -34.0% -99.93%
Total Long-Term Liabilities $66.00K $76.00K $105.4M
YoY Change -34.0% -99.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $92.54M $94.49M $107.3M
Total Long-Term Liabilities $66.00K $76.00K $105.4M
Total Liabilities $146.3M $159.3M $212.7M
YoY Change -28.05% -25.09%
SHAREHOLDERS EQUITY
Retained Earnings -$229.0M -$195.1M -$116.1M
YoY Change 77.83% 68.07%
Common Stock $689.3M $678.4M $410.9M
YoY Change 66.98% 65.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $459.6M $483.1M $294.7M
YoY Change
Total Liabilities & Shareholders Equity $605.9M $642.5M $507.4M
YoY Change 24.37% 26.63%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$33.90M -$28.58M -$7.986M
YoY Change 167.14% 257.9% -30.07%
Depreciation, Depletion And Amortization $689.0K $700.0K $500.0K
YoY Change 37.8% 40.0% 150.0%
Cash From Operating Activities -$38.35M -$37.26M $131.7M
YoY Change 90.81% -128.29% -1153.6%
INVESTING ACTIVITIES
Capital Expenditures -$501.0K -$306.0K -$2.400M
YoY Change -64.21% -87.25% -1300.0%
Acquisitions
YoY Change
Other Investing Activities -$67.52M -$136.6M -$331.9M
YoY Change 2496.85% -58.86% 324.97%
Cash From Investing Activities -$68.02M -$136.9M -$334.3M
YoY Change 1600.47% -59.06% 326.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.054M 246.0M 196.3M
YoY Change 584.67% 25.34% -196400.0%
NET CHANGE
Cash From Operating Activities -38.35M -37.26M 131.7M
Cash From Investing Activities -68.02M -136.9M -334.3M
Cash From Financing Activities 2.054M 246.0M 196.3M
Net Change In Cash -104.3M 71.92M -6.300M
YoY Change 338.31% -1241.54% -93.07%
FREE CASH FLOW
Cash From Operating Activities -$38.35M -$37.26M $131.7M
Capital Expenditures -$501.0K -$306.0K -$2.400M
Free Cash Flow -$37.85M -$36.95M $134.1M
YoY Change 102.41% -127.56% -1155.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
kymr Proceeds From Concurrent Private Placement Follow On
ProceedsFromConcurrentPrivatePlacementFollowOn
kymr Tenant Improvements Included In Other Assets
TenantImprovementsIncludedInOtherAssets
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
kymr Offering Costs Included In Accrued Liabilities
OfferingCostsIncludedInAccruedLiabilities
kymr Reduction Of Right Of Use Asset And Liability Due To Lease Modification
ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001815442
kymr Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
kymr Proceeds From Concurrent Private Placement
ProceedsFromConcurrentPrivatePlacement
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2021Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
kymr:CollaborationsRevenueMember
kymr Net Operating Loss Carryforwards Period Cares Act
NetOperatingLossCarryforwardsPeriodCARESAct
P5Y
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
9050000
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
kymr:CollaborationsRevenueMember
CY2020Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
kymr:CollaborationsRevenueMember
kymr Non Cash Research And Development Expense
NonCashResearchAndDevelopmentExpense
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
kymr:CollaborationsRevenueMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39460
dei Entity Registrant Name
EntityRegistrantName
KYMERA THERAPEUTICS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2992166
dei Entity Address Address Line1
EntityAddressAddressLine1
200 Arsenal Yards Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
857
dei Local Phone Number
LocalPhoneNumber
285-5300
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
KYMR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51387136
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156819000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31004000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
379567000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
265198000
CY2021Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
577000
CY2021Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1573000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
856000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5772000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4704000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
543731000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
302339000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
74692000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
162531000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12184000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10841000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9540000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9845000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
716000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1590000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1589000
CY2021Q3 us-gaap Assets
Assets
642453000
CY2020Q4 us-gaap Assets
Assets
487175000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5033000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4368000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19219000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10330000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
66234000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
92552000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2443000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2572000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1189000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
689000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
375000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
106000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
94493000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
110617000
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
49939000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
77838000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13463000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14128000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1347000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
604000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
76000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
100000
CY2021Q3 us-gaap Liabilities
Liabilities
159318000
CY2020Q4 us-gaap Liabilities
Liabilities
203287000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51311921
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44592288
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51256553
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44482186
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
5000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
678358000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
412777000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-195082000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128765000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-146000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-128000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
483135000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
283888000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
642453000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
487175000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20336000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14533000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57557000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21249000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38306000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15778000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
99488000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41713000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10667000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6838000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24605000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13058000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
48973000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
22616000
us-gaap Operating Expenses
OperatingExpenses
124093000
us-gaap Operating Expenses
OperatingExpenses
54771000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-28637000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8083000
us-gaap Operating Income Loss
OperatingIncomeLoss
-66536000
us-gaap Operating Income Loss
OperatingIncomeLoss
-33522000
CY2021Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
125000
CY2020Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
125000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
343000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
702000
CY2021Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
70000
CY2020Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
28000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
124000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
88000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
55000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
97000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
219000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
614000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28582000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7986000
us-gaap Net Income Loss
NetIncomeLoss
-66317000
us-gaap Net Income Loss
NetIncomeLoss
-32908000
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-146000
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-195000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-18000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-170000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28728000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8181000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-66335000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33078000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28582000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7986000
us-gaap Net Income Loss
NetIncomeLoss
-66317000
us-gaap Net Income Loss
NetIncomeLoss
-32908000
CY2021Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
CY2020Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28582000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7986000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-66317000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41958000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.56
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.42
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.11
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50714846
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20677392
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46841636
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8211003
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-107289000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
110000
CY2020Q3 kymr Stock Issued During Period Value Restricted Stock Vested
StockIssuedDuringPeriodValueRestrictedStockVested
111000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2328000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-195000
CY2020Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17003000
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
211332000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7986000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
294685000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
258104000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3257000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7396000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-146000
CY2021Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
16207000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28582000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
483135000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-74406000
kymr Exchange Of Convertible Preferred Stock Impact On Equity
ExchangeOfConvertiblePreferredStockImpactOnEquity
-9049000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
138000
kymr Stock Issued During Period Value Restricted Stock Vested
StockIssuedDuringPeriodValueRestrictedStockVested
110000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3363000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-170000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17003000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
211332000
us-gaap Net Income Loss
NetIncomeLoss
-32908000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
294685000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
283888000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5875000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
307000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16294000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-18000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
16207000
us-gaap Net Income Loss
NetIncomeLoss
-66317000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
483135000
us-gaap Profit Loss
ProfitLoss
-66317000
us-gaap Profit Loss
ProfitLoss
-32908000
us-gaap Share Based Compensation
ShareBasedCompensation
16294000
us-gaap Share Based Compensation
ShareBasedCompensation
3363000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1708000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1266000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
4171000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-18000
kymr Non Cash Research And Development Expense
NonCashResearchAndDevelopmentExpense
332000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1068000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1440000
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-577000
kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
717000
kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
577000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1082000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
523000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8803000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2268000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-54217000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
129328000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-305000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-8330000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-794000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2287000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
439000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90594000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
108198000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1096000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7659000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
292006000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
460939000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
261286000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
50000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31816000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-418598000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5874000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
138000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
307000
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
397000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
693000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
402000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
182748000
kymr Proceeds From Concurrent Private Placement
ProceedsFromConcurrentPrivatePlacement
13527000
kymr Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
240788000
kymr Proceeds From Concurrent Private Placement Follow On
ProceedsFromConcurrentPrivatePlacementFollowOn
2347000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
248226000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
288992000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
125816000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21408000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32593000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
77789000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
158409000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56381000
us-gaap Interest Paid Net
InterestPaidNet
106000
us-gaap Interest Paid Net
InterestPaidNet
88000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
65000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
797000
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
1918000
kymr Offering Costs Included In Accrued Liabilities
OfferingCostsIncludedInAccruedLiabilities
28000
kymr Tenant Improvements Included In Other Assets
TenantImprovementsIncludedInOtherAssets
139000
kymr Reduction Of Right Of Use Asset And Liability Due To Lease Modification
ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification
2161000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156819000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54593000
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
1590000
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
1788000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
158409000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56381000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-195100000
CY2021Q3 us-gaap Investments And Cash
InvestmentsAndCash
611100000
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On August 20, 2020, the Board approved a 1-for-1.5949 reverse stock split of the Company’s issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each of the Company’s outstanding series of preferred stock. All share and per share amounts in the accompanying condensed consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to this reverse stock split, including reclassifying an amount equal to the reduction in par value of common stock to additional paid-in capital.
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.5949
CY2021Q3 us-gaap Change In Accounting Principle Accounting Standards Update Adoption Date
ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
2021-01-01
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q3 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2020Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2021Q3 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2020Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2021Q3 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2020Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2021Q3 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2020Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
454405000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
28000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
174000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
454259000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
427863000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
134000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
427729000
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
79
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
286600000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
65
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
392200000
kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
77
CY2021Q3 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
379600000
kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
24
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
74700000
CY2020 kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
48
CY2020Q4 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
295600000
CY2020 kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
25
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
162500000
CY2021Q3 us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
CY2020Q3 us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
79
CY2020Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
1433000
kymr Contract With Customer Asset Net Additions
ContractWithCustomerAssetNetAdditions
5961000
kymr Contract With Customer Asset Net Deductions
ContractWithCustomerAssetNetDeductions
5821000
CY2021Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
1573000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
170390000
kymr Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
3339000
kymr Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
-57556000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
116173000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15411000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12988000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3227000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2147000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12184000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10841000
CY2021Q3 us-gaap Depreciation
Depreciation
700000
CY2020Q3 us-gaap Depreciation
Depreciation
500000
us-gaap Depreciation
Depreciation
1700000
us-gaap Depreciation
Depreciation
1300000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
300000
CY2020Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
200000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
700000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
500000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
524000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
606000
us-gaap Operating Lease Cost
OperatingLeaseCost
1571000
us-gaap Operating Lease Cost
OperatingLeaseCost
2195000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
279000
CY2020Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
183000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
650000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
539000
CY2021Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
52000
CY2020Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
29000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
106000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
94000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
358000
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
216000
us-gaap Variable Lease Cost
VariableLeaseCost
743000
us-gaap Variable Lease Cost
VariableLeaseCost
431000
CY2021Q3 us-gaap Lease Cost
LeaseCost
1213000
CY2020Q3 us-gaap Lease Cost
LeaseCost
1034000
us-gaap Lease Cost
LeaseCost
3070000
us-gaap Lease Cost
LeaseCost
3259000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
2060000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
-3793000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
593000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
437000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
106000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
94000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y7M2D
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y7M2D
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M9D
CY2020Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y11M26D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1050
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1050
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0875
CY2020Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.081
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
631000
CY2021Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
309000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2581000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1183000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2659000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
969000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2732000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
345000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2814000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2021Q3 kymr Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
12925000
CY2021Q3 kymr Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
0
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24342000
CY2021Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2806000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8436000
CY2021Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
270000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
15906000
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
2536000
CY2021Q3 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
12603000
CY2020Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
5821000
CY2021Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3866000
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2918000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2193000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1585000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
557000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19219000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10330000
CY2020Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
6.5366
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7396000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y21D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M15D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M9D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.066
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.77
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.78
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0091
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0035
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0090
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0051
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2328000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16294000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3363000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
kymr Net Operating Loss Carryforwards Percentage Limitations On Use Cares Act
NetOperatingLossCarryforwardsPercentageLimitationsOnUseCARESAct
0.80
kymr Expected Income Tax Refund Period Cares Act
ExpectedIncomeTaxRefundPeriodCARESAct
P18M
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28582000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7986000
us-gaap Net Income Loss
NetIncomeLoss
-66317000
us-gaap Net Income Loss
NetIncomeLoss
-32908000
CY2021Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
CY2020Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
9050000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28582000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7986000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-66317000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41958000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50714846
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20677392
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46841636
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8211003
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.56
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.42
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.11
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6680923
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5785042

Files In Submission

Name View Source Status
0000950170-21-003911-index-headers.html Edgar Link pending
0000950170-21-003911-index.html Edgar Link pending
0000950170-21-003911.txt Edgar Link pending
0000950170-21-003911-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kymr-20210930.htm Edgar Link pending
kymr-20210930.xsd Edgar Link pending
kymr-20210930_cal.xml Edgar Link unprocessable
kymr-20210930_def.xml Edgar Link unprocessable
kymr-20210930_htm.xml Edgar Link completed
kymr-20210930_lab.xml Edgar Link unprocessable
kymr-20210930_pre.xml Edgar Link unprocessable
kymr-ex31_1.htm Edgar Link pending
kymr-ex31_2.htm Edgar Link pending
kymr-ex32_1.htm Edgar Link pending
kymr-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending